Notice of Intent to Sole Source Deployed Medicine Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA), specifically the Medical Simulation and Training Program Management Office (MST PMO), has issued a Notice of Intent to Sole Source for Deployed Medicine Services. DHA intends to award a contract to Allogy, LLC for the sustainment and enhancement of the Deployed Medicine platform (formerly Joint Trauma and Education Training Delivery Platform - JTETDP) for the next five years. This notice is not a request for competitive proposals.
Scope of Work
The required services include comprehensive management of the Deployed Medicine platform, which is built on and managed with Allogy, LLC's proprietary Capillary platform. Key services encompass software configuration control, ongoing software sustainment, content updates, cloud hosting services, and technical/help desk support. Additionally, the contractor will be responsible for incorporating new capabilities into the platform as needed. Allogy, LLC is identified as the sole owner of the Capillary code base.
Contract & Timeline
- Type: Notice of Intent to Sole Source
- Duration: Five (5) years
- Set-Aside: Total Small Business Set-Aside (FAR 19.5)
- Response Due: April 24, 2026, 5:00 PM ET
- Published: April 13, 2026
Evaluation
This is a Notice of Intent to award a sole source contract and is explicitly not a request for competitive proposals or offers. No solicitation package is available. The agency has determined that Allogy, LLC is the only responsible source capable of satisfying the requirements due to their proprietary ownership of the Capillary platform. Responses to this synopsis will be reviewed by military personnel, Government civilians, and associated support contractors, but no feedback or evaluations will be provided, and submissions will not be returned.
Additional Notes
Telephone inquiries will not be accepted or acknowledged. Any information submitted will not be disclosed outside DHA.